{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease (AD)", "acetylcholinesterase", "everolimus", "mTOR", "oxidative stress", "streptozotocin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30564080", "DateRevised": {"Year": "2024", "Month": "07", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.17179/excli2018-1626"], "Journal": {"ISSN": "1611-2156", "JournalIssue": {"Volume": "17", "PubDate": {"Year": "2018"}}, "Title": "EXCLI journal", "ISOAbbreviation": "EXCLI J"}, "ArticleTitle": "Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats.", "Pagination": {"StartPage": "999", "EndPage": "1017", "MedlinePgn": "999-1017"}, "Abstract": {"AbstractText": ["Everolimus (EVR), as a rapamycin analog, is a selective inhibitor of the mammalian target of rapamycin (mTOR) kinase and its associated signaling pathway. mTOR is a serine/threonine protein kinase and its hyperactivity is involved in the pathophysiology of Alzheimer's disease (AD) and associated cognitive deficits. The present study evaluated the impact of EVR, on cognitive functions, hippocampal cell loss, and neurochemical parameters in the intracerebroventricular streptozotocin (icv-STZ) model of AD rats. EVR (1 and 5 mg/kg) was administered for 21 days following the single administration of STZ (3 mg/kg, icv) or for 7 days on days 21-28 post-STZ injection after establishment of cognitive dysfunction. Cognitive deficits (passive avoidance and spatial memory), oxidative stress parameters, acetylcholinesterase (AChE) activity, and percentage of cell loss were evaluated in the hippocampus. Chronic administration (1 and 5 mg/kg for 21 days from the day of surgery and icv-STZ infusion) or acute injection (5 mg/kg for 7 days after establishment of cognitive impairment) of EVR significantly attenuated cognitive dysfunction, neuronal loss, oxidative stress and AChE activity in the hippocampus of STZ-AD rats. In conclusion, our study showed that EVR could prevent or improve deteriorations in behavioral, biochemical and histopathological features of the icv-STZ rat model of AD. Therefore, inhibition of the hyperactivated mTOR may be an important therapeutic target for AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Fanoudi", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hosseini", "ForeName": "Mahmoud", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Alavi", "ForeName": "Mohaddeseh Sadat", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Boroushaki", "ForeName": "Mohammad Taher", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hosseini", "ForeName": "Azar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sadeghnia", "ForeName": "Hamid R", "Initials": "HR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "EXCLI J", "NlmUniqueID": "101299402", "ISSNLinking": "1611-2156"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abada A, Elazar Z. Getting ready for building: signaling and autophagosome biogenesis. EMBO Rep. 2014:e201439076.", "ArticleIdList": ["PMC4197041", "25027988"]}, {"Citation": "Agrawal R, Tyagi E, Shukla R, Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology. 2009;56:779\u2013787.", "ArticleIdList": ["19705549"]}, {"Citation": "An W-L, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, et al. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's Disease. Am J Pathol. 2003;163:591\u2013607.", "ArticleIdList": ["PMC1868198", "12875979"]}, {"Citation": "Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch Pharm Res. 2013;36:375\u2013399.", "ArticleIdList": ["23435942"]}, {"Citation": "Ashrafpour M, Parsaei S, Sepehri H. Quercetin improved spatial memory dysfunctions in rat model of intracerebroventricular streptozotocin-induced sporadic Alzheimer\u2019sdisease. Natl J Physiol Pharm Pharmacol. 2015;5:411\u2013415."}, {"Citation": "Barone E, Di Domenico F, Cassano T, Arena A, Tramutola A, Lavecchia MA, et al. Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radic Biol Med. 2016;91:127\u2013142.", "ArticleIdList": ["26698666"]}, {"Citation": "Bassani TB, Turnes JM, Moura EL, Bonato JM, C\u00f3ppola-Segovia V, Zanata SM, et al. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer\u2019s type. Behav Brain Res. 2017;335:41\u201354.", "ArticleIdList": ["28801114"]}, {"Citation": "Blagosklonny MV. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012;181:1142\u20131146.", "ArticleIdList": ["22841821"]}, {"Citation": "Bolduc FV, Bell K, Cox H, Broadie KS, Tully T. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci. 2008;11:1143\u20131145.", "ArticleIdList": ["PMC3038669", "18776892"]}, {"Citation": "Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u2013259.", "ArticleIdList": ["1759558"]}, {"Citation": "Brewster AL, Lugo JN, Patil VV, Lee WL, Qian Y, Vanegas F, et al. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PLoS One. 2013;8:e57808.", "ArticleIdList": ["PMC3594232", "23536771"]}, {"Citation": "Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell. 2013;12:370\u2013380.", "ArticleIdList": ["PMC3655115", "23425014"]}, {"Citation": "Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285:13107\u201313120.", "ArticleIdList": ["PMC2857107", "20178983"]}, {"Citation": "Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi SH, et al. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease? J Neurosci Res. 2012;90:1105\u20131118.", "ArticleIdList": ["22344941"]}, {"Citation": "Calap-Quintana P, Soriano S, Llorens JV, Al-Ramahi I, Botas J, Molto MD, et al. TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich's Ataxia. PLoS One. 2015;10:e0132376.", "ArticleIdList": ["PMC4497667", "26158631"]}, {"Citation": "Casey DA, Antimisiaris D, O\u2019Brien J. Drugs for Alzheimer\u2019s disease: are they effective? P & T. 2010;35:208.", "ArticleIdList": ["PMC2873716", "20498822"]}, {"Citation": "Chen L, Zhang Y, Li D, Zhang N, Liu R, Han B, et al. Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway. J Neuroimmunol. 2016;299:164\u2013171.", "ArticleIdList": ["27725116"]}, {"Citation": "Chong ZZ, Shang YC, Zhang L, Wang S, Maiese K. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev. 2010;3:374\u2013391.", "ArticleIdList": ["PMC3154047", "21307646"]}, {"Citation": "Damme M, Suntio T, Saftig P, Eskelinen E-L. Autophagy in neuronal cells: general principles and physiological and pathological functions. Acta Neuropathol. 2015;129:337\u2013362.", "ArticleIdList": ["25367385"]}, {"Citation": "Dann SG, Selvaraj A, Thomas G. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med. 2007;13:252\u2013259.", "ArticleIdList": ["17452018"]}, {"Citation": "Darreh-Shori T, Hellstrom-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J Neurochem. 2004;88:1102\u20131113.", "ArticleIdList": ["15009666"]}, {"Citation": "Dash PK, Orsi SA, Moore AN. Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex\u2013mammalian target of rapamycin pathway. J Neurosci. 2006;26:8048\u20138056.", "ArticleIdList": ["PMC6673778", "16885218"]}, {"Citation": "D'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 2001;36:60\u201390.", "ArticleIdList": ["11516773"]}, {"Citation": "Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats. J Mol Neurosci. 2012;46:223\u2013235.", "ArticleIdList": ["21701788"]}, {"Citation": "Ebrahimi K, Majdi A, Baghaiee B, Hosseini SH, Sadigh-Eteghad S. Physical activity and beta-amyloid pathology in Alzheimer's disease: A sound mind in a sound body. EXCLI J. 2017;16:959\u2013972.", "ArticleIdList": ["PMC5579405", "28900376"]}, {"Citation": "Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395.", "ArticleIdList": ["13726518"]}, {"Citation": "Gupta A, Dey CS. PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance. Mol Biol Cell. 2012;23:3882\u20133898.", "ArticleIdList": ["PMC3459864", "22875989"]}, {"Citation": "Gutierres JM, Carvalho FB, Schetinger MR, Marisco P, Agostinho P, Rodrigues M, et al. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type. Life Sci. 2014;96:7\u201317.", "ArticleIdList": ["24291256"]}, {"Citation": "Hamilton A, Holscher C. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/ PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res. 2012;1449:83\u201393.", "ArticleIdList": ["22418058"]}, {"Citation": "Hasskarl J. Everolimus. Recent Results Cancer Res. 2014;201:373\u2013392.", "ArticleIdList": ["24756805"]}, {"Citation": "Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci. 2005;8:394\u2013399.", "ArticleIdList": ["16401389"]}, {"Citation": "Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA, et al. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res. 2006;171:9\u201316.", "ArticleIdList": ["16621054"]}, {"Citation": "Isomae K, Ishikawa M, Ohta M, Ogawa Y, Hasegawa H, Kohda T, et al. Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain. Jpn J Pharmacol. 2002;88:206\u2013212.", "ArticleIdList": ["11928722"]}, {"Citation": "Javed H, Khan M, Ahmad A, Vaibhav K, Ahmad M, Khan A, et al. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience. 2012;210:340\u2013352.", "ArticleIdList": ["22441036"]}, {"Citation": "Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338\u2013345.", "ArticleIdList": ["PMC3687363", "23325216"]}, {"Citation": "Kamat PK. Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism. Neural Regen Res. 2015;10:1050\u20131052.", "ArticleIdList": ["PMC4541228", "26330820"]}, {"Citation": "Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology. Mol Neurobiol. 2016;53:4548\u20134562.", "ArticleIdList": ["26298663"]}, {"Citation": "Kezic A, Thaiss F, Becker JU, Tsui TY, Bajcetic M. Effects of everolimus on oxidative stress in kidney model of ischemia/reperfusion injury. Am J Nephrol. 2013;37:291\u2013301.", "ArticleIdList": ["23548777"]}, {"Citation": "Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol. 2006;16:230\u2013241.", "ArticleIdList": ["16461276"]}, {"Citation": "Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u2013141.", "ArticleIdList": ["PMC3987946", "21258367"]}, {"Citation": "Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, et al. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J Neurochem. 2005;94:215\u2013225.", "ArticleIdList": ["15953364"]}, {"Citation": "Lagarde J, Sarazin M, Chauvire V, Stankoff B, Kas A, Lacomblez L, et al. Cholinergic changes in aging and Alzheimer Disease: An [18F]-F-A-85380 exploratory PET study. Alzheimer Dis Assoc Disord. 2017;31:8\u201312.", "ArticleIdList": ["27680780"]}, {"Citation": "Lang UE, Heger J, Willbring M, Domula M, Matschke K, Tugtekin SM. Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. Transplant Proc. 2009;41:4285\u20134288.", "ArticleIdList": ["20005385"]}, {"Citation": "Li L, Zhang X, Le W. Autophagy dysfunction in Alzheimer\u2019s disease. Neurodegener Dis. 2010;7:265\u2013271.", "ArticleIdList": ["20551691"]}, {"Citation": "Lu Q, Zhou Y, Hao M, Li C, Wang J, Shu F, et al. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy. Mol Cell Endocrinol. 2018;473:31\u201343.", "ArticleIdList": ["29277549"]}, {"Citation": "Maiese K. Driving neural regeneration through the mammalian target of rapamycin. Neural Regen Res. 2014;9:1413.", "ArticleIdList": ["PMC4192939", "25317149"]}, {"Citation": "Maiese K, Chong ZZ, Shang YC, Wang S. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med. 2013;19:51\u201360.", "ArticleIdList": ["PMC3534789", "23265840"]}, {"Citation": "Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, et al. Lifelong rapamycin administration ameliorates age\u2010dependent cognitive deficits by reducing IL\u20101\u03b2 and enhancing NMDA signaling. Aging Cell. 2012;11:326\u2013335.", "ArticleIdList": ["PMC3306461", "22212527"]}, {"Citation": "Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y, Sarkaki A, Bavarsad K. Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats. Pharmacol Biochem Behav. 2013;111:90\u201396.", "ArticleIdList": ["24036471"]}, {"Citation": "Mehla J, Pahuja M, Gupta YK. Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose. J Alzheimers Dis. 2013;33:17\u201321.", "ArticleIdList": ["22886014"]}, {"Citation": "Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069.", "ArticleIdList": ["PMC2670399", "18305538"]}, {"Citation": "Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth. 1984;11:47\u201360.", "ArticleIdList": ["6471907"]}, {"Citation": "Nazifi M, Oryan S, Eslimi Esfahani D, Moghadamnia A, Ashrafpour M. Chronic administration of piperine attenuates behavioural, biochemical and histological alterations induced by intracerebroventricular streptozotocin in rats. Basic Clin Pharmacol Toxicol. 2018:epub ahead of print."}, {"Citation": "Nitsch R, Hoyer S. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett. 1991;128:199\u2013202.", "ArticleIdList": ["1834965"]}, {"Citation": "Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.", "ArticleIdList": ["6110810"]}, {"Citation": "Pei JJ, Hugon J. mTOR\u2010dependent signalling in Alzheimer's disease. J Cell Mol Med. 2008;12:2525\u20132532.", "ArticleIdList": ["PMC3828871", "19210753"]}, {"Citation": "Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015;84:39\u201349.", "ArticleIdList": ["25796566"]}, {"Citation": "Perluigi M, Pupo G, Tramutola A, Cini C, Coccia R, Barone E, et al. Neuropathological role of PI3K/Akt/ mTOR axis in Down syndrome brain. Biochim Biophys Acta. 2014;1842:1144\u20131153.", "ArticleIdList": ["PMC4062876", "24735980"]}, {"Citation": "Ponce-Lopez T, Liy-Salmeron G, Hong E, Meneses A. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3beta decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. Brain Res. 2011;1426:73\u201385.", "ArticleIdList": ["22036080"]}, {"Citation": "Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer's disease and its models. Neuroscience. 2013;251:51\u201365.", "ArticleIdList": ["22687952"]}, {"Citation": "Ramezani M, Darbandi N, Khodagholi F, Hashemi A. Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer's disease. Neural Regen Res. 2016;11:1976\u20131980.", "ArticleIdList": ["PMC5270437", "28197195"]}, {"Citation": "Reeta KH, Mehla J, Gupta YK. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res. 2009;1301:52\u201360.", "ArticleIdList": ["19765566"]}, {"Citation": "Richardson A, Galvan V, Lin A-L, Oddo S. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story. Exp Gerontol. 2015;68:51\u201358.", "ArticleIdList": ["PMC6417920", "25481271"]}, {"Citation": "Russo E, Citraro R, Constanti A, De Sarro G. The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol. 2012;46:662\u2013681.", "ArticleIdList": ["22825882"]}, {"Citation": "Russo E, Leo A, Crupi R, Aiello R, Lippiello P, Spiga R, et al. Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression. J Psychiatr Res. 2016;78:1\u201310.", "ArticleIdList": ["27019134"]}, {"Citation": "Sadeghnia HR, Shaterzadeh H, Forouzanfar F, Hosseinzadeh H. Neuroprotective effect of safranal, an active ingredient of Crocus sativus , in a rat model of transient cerebral ischemia. Folia Neuropathol. 2017;55:206\u2013213.", "ArticleIdList": ["28984113"]}, {"Citation": "Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer\u2019s disease, about the therapeutic strategies in Alzheimer\u2019s research. J Neural Transm. 2013;120:233\u2013252.", "ArticleIdList": ["22886150"]}, {"Citation": "Sanchez-Fructuoso AI. Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials. Expert Opin Drug Metab Toxicol. 2008;4:807\u2013819.", "ArticleIdList": ["18611120"]}, {"Citation": "Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22:159\u2013168.", "ArticleIdList": ["16603397"]}, {"Citation": "Saxena G, Singh SP, Agrawal R, Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol. 2008;581:283\u2013289.", "ArticleIdList": ["18234183"]}, {"Citation": "Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 2001;68:1021\u20131029.", "ArticleIdList": ["11212865"]}, {"Citation": "Sharma V, Bala A, Deshmukh R, Bedi KL, Sharma PL. Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav. 2012;101:239\u2013245.", "ArticleIdList": ["22285388"]}, {"Citation": "Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology. 2007;52:836\u2013843.", "ArticleIdList": ["17123555"]}, {"Citation": "Singh AK, Kashyap MP, Tripathi VK, Singh S, Garg G, Rizvi SI. Neuroprotection through rapamycin-induced activation of autophagy and PI3K/Akt1/ mTOR/CREB signaling against amyloid-\u03b2-induced oxidative stress, synaptic/neurotransmission dysfunction, and neurodegeneration in adult rats. Mol Neurobiol. 2017;54:5815\u20135828.", "ArticleIdList": ["27660271"]}, {"Citation": "Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer's disease. PLoS One. 2010;5:e9979.", "ArticleIdList": ["PMC2848616", "20376313"]}, {"Citation": "Stuchbury G, M\u00fcnch G. Alzheimer\u2019s associated inflammation, potential drug targets and future therapies. J Neural Transm. 2005;112:429\u2013453.", "ArticleIdList": ["15723159"]}, {"Citation": "Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, et al. Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res. 2008;5:525\u2013532.", "ArticleIdList": ["PMC2780015", "19075578"]}, {"Citation": "Sultana R, Butterfield DA. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. J Alzheimers Dis. 2013;33(Suppl 1):S243\u2013S251.", "ArticleIdList": ["22683528"]}, {"Citation": "Tang Z, Ioja E, Bereczki E, Hultenby K, Li C, Guan Z, et al. mTor mediates tau localization and secretion: Implication for Alzheimer's disease. Biochim Biophys Acta. 2015;1853:1646\u20131657.", "ArticleIdList": ["25791428"]}, {"Citation": "Texel SJ, Mattson MP. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid Redox Signal. 2011;14:1519\u20131534.", "ArticleIdList": ["PMC3061199", "20849373"]}, {"Citation": "Tiwari V, Kuhad A, Bishnoi M, Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative\u2013nitrosative stress in rats. Pharmacol Biochem Behav. 2009;93:183\u2013189.", "ArticleIdList": ["19464315"]}, {"Citation": "Tramutola A, Triplett JC, Di Domenico F, Niedowicz DM, Murphy MP, Coccia R, et al. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J Neurochem. 2015;133:739\u2013749.", "ArticleIdList": ["25645581"]}, {"Citation": "Troca-Mar\u00edn JA, Alves-Sampaio A, Montesinos ML. Deregulated mTOR-mediated translation in intellectual disability. Prog Neurobiol. 2012;96:268\u2013282.", "ArticleIdList": ["22285767"]}, {"Citation": "Vafaee F, Hosseini M, Hassanzadeh Z, Edalatmanesh MA, Sadeghnia HR, Seghatoleslam M, et al. The effects of Nigella sativa hydro-alcoholic extract on memory and brain tissues oxidative damage after repeated seizures in rats. Iranian journal of pharmaceutical research: IJPR. 2015;14:547.", "ArticleIdList": ["PMC4403072", "25901163"]}, {"Citation": "Veerendra Kumar M, Gupta Y. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol. 2003;30:336\u2013342.", "ArticleIdList": ["12859423"]}, {"Citation": "Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L. Targeting the mTOR signaling network for Alzheimer's disease therapy. Mol Neurobiol. 2014;49:120\u2013135.", "ArticleIdList": ["23853042"]}, {"Citation": "Wang J, Yang X, Zhang J. Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic beta cells. Cell Signal. 2016;28:1099\u20131104.", "ArticleIdList": ["27185188"]}, {"Citation": "Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013;36:40\u201350.", "ArticleIdList": ["PMC3880546", "23644232"]}, {"Citation": "Yates DH. mTOR treatment in lymphangioleiomyomatosis: the role of everolimus. Expert Rev Respir Med. 2016;10:249\u2013260.", "ArticleIdList": ["26847859"]}, {"Citation": "Yokomasu A, Yano I, Sato E, Masuda S, Katsura T, Inui K. Effect of itraconazole on the pharmacokinetics of everolimus administered by different routes in rats. Biopharm Drug Dispos. 2009;30:517\u2013523.", "ArticleIdList": ["19790241"]}, {"Citation": "Zabihi H, Hosseini M, Pourganji M, Oryan S, Soukhtanloo M, Niazmand S. The effects of tamoxifen on learning, memory and brain tissues oxidative damage in ovariectomized and naive female rats. Adv Biomed Res. 2014;3:219.", "ArticleIdList": ["PMC4219215", "25371876"]}, {"Citation": "Zhao D, Yang J, Yang L. Insights for oxidative stress and mTOR signaling in myocardial ischemia/reperfusion injury under diabetes. Oxid Med Cell Longev. 2017;2017:6437467.", "ArticleIdList": ["PMC5337354", "28298952"]}, {"Citation": "Zhong S-Z, Ge Q-H, Qu R, Li Q, Ma S-P. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. J Neurol Sci. 2009;277:58\u201364.", "ArticleIdList": ["19007942"]}, {"Citation": "Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE. 2005;2005:pe4.", "ArticleIdList": ["15671481"]}]}], "History": [{"Year": "2018", "Month": "8", "Day": "16"}, {"Year": "2018", "Month": "10", "Day": "5"}, {"Year": "2018", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "10", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["30564080", "PMC6295637", "10.17179/excli2018-1626", "2018-1626"]}}]}